NRIM Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
69.9M
+9.4%
63.9M
+6.9%
59.8M
-4.1%
62.3M
-19.3%
77.2M
Cost of Revenue
10.3M
+2.6%
10.0M
-2.1%
10.2M
-4.0%
10.7M
+0.3%
10.6M
Gross Profit
59.6M
+10.7%
53.9M
+8.7%
49.5M
-4.1%
51.7M
-22.4%
66.6M
Operating Expenses
33.2M
+3.6%
32.0M
+4.6%
30.6M
-8.4%
33.4M
+10.3%
30.3M
R&D
—
—
—
—
—
SG&A
8.6M
+15.3%
7.4M
-0.6%
7.5M
-8.6%
8.2M
+20.5%
6.8M
Operating Income
18.7M
-7.3%
20.2M
+12.6%
18.0M
+8.1%
16.6M
-52.0%
34.6M
EBITDA
18.7M
-7.3%
20.2M
+12.6%
18.0M
+8.1%
16.6M
-52.0%
34.6M
Net Income
14.4M
-6.1%
15.3M
+12.2%
13.7M
+9.9%
12.4M
-54.0%
27.1M
EPS (Basic)
$0.64
-7.2%
$0.69
+11.3%
$0.62
+10.7%
$0.56
-54.5%
$1.23
EPS (Diluted)
$0.63
-7.4%
$0.68
+11.5%
$0.61
+10.9%
$0.55
-54.2%
$1.20
Shares (Diluted)
22.6M
+0.1%
22.5M
-0.1%
22.6M
+0.1%
22.6M
+0.3%
22.5M
Northrim Ban (NRIM) — Financials